CurveBeam AI Ltd. engages in the research, design, and manufacture of cone beam computed tomography imaging systems. It operates through the following geographical segments: North America, Europe, and Rest of World. The company was founded in September 2022 and is headquartered in Melbourne, Australia.
Sector:
Health Technology
Industry:
Biotechnology
Employees:
N/A
Frequently Asked Questions
Market cap, also known as market capitalization, is the total market value of a company. It's calculated by multiplying the current market price by the total number of shares outstanding. CurveBeam AI Ltd. market cap is $46.82M.
52 week high is the highest price of a stock in the past 52 weeks, or one year. CurveBeam AI Ltd. 52 week high is $0.054 as of November 22, 2026.
52 week low is the lowest price of a stock in the past 52 weeks, or one year. CurveBeam AI Ltd. 52 week low is $0.054 as of November 22, 2026.
CurveBeam AI Ltd. stock price today is $0.054.
The Price-to-Earnings (or P/E) ratio is a commonly used tool for valuing a company. It's calculated by dividing the current share price by the earnings per share (or EPS). It can also be calculated by dividing the company's Market Cap by the Net Profit. CurveBeam AI Ltd.'s P/E ratio is -1.9.
The Price-to-Book (P/B) ratio is a commonly used tool for valuing a company. It's calculated by dividing a company's market capitalization by its book value. CurveBeam AI Ltd. P/B ratio is 1.3337.
The 50-day moving average is a frequently used data point by active investors and traders to understand the trend of a stock. It's calculated by averaging the closing stock price over the previous 50 trading days. CurveBeam AI Ltd. 50-day moving average is $0.054.